The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease

scientific article published on 01 July 2004

The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1067262102
P356DOI10.14310/HORM.2002.11126
P2888exact matchhttps://scigraph.springernature.com/pub.10.14310/horm.2002.11126
P698PubMed publication ID16982592

P50authorAllan FlyvbjergQ49252518
P2093author name stringJan Frystyk
Gerasimos Krassas
Jian-Wen Chen
Nikolaos Pontikides
Argyrios Dumas
P433issue3
P921main subjecteye diseaseQ3041498
P304page(s)191-197
P577publication date2004-07-01
P1433published inHormones : international journal of endocrinology and metabolismQ26839920
P1476titleThe effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease
P478volume3

Reverse relations

Q35785161Somatostatin analogs: a new tool for the management of Graves' ophthalmopathycites workP2860

Search more.